Analysis of HLA class II and TAP alleles in Japanese patients with psoriasis vulgaris. 1998

H Saeki, and S Kuwata, and H Nakagawa, and A Asahina, and K Tamaki, and Y Shibata, and T Juji
Department of Dermatology, Faculty of Medicine, University of Tokyo, Japan.

We investigated HLA class II and transporter associated with antigen processing (TAP) alleles in eighty-five unrelated Japanese patients with psoriasis vulgaris and fifty-two healthy controls using the polymerase chain reaction-restriction fragment length polymorphism method. The frequencies of DRB1*1502 and DQB1*0601 were increased in the patient group (DRB1*1502; 21% vs 12%, p < 0.05, DQB1*0601; 35% vs. 21%, p < 0.05), while the frequencies of DRB1*0406 and TAP2*E were decreased in the patients (DRB1*0406; 2% vs 9%, p < 0.05, TAP2*E; 4% vs 11%, p < 0.05). However, none of these remained significant after p values were corrected for the number of comparisons made (pc > 0.05). We also analysed specific amino acids on HLA class II molecules, but no significant difference was found between the two groups. Our previous reports clarified that aspartate at residue 9 (48% vs 20%, p < 0.002) and alanine at residue 73 (81% vs 48%, p < 0.0001) on HLA-C molecules were strongly associated with Japanese patients with PsV. These specific amino acids on HLA-C molecules are supposed to play more important roles compared with HLA class II and TAP alleles in the development of psoriasis vulgaris.

UI MeSH Term Description Entries
D007564 Japan A country in eastern Asia, island chain between the North Pacific Ocean and the Sea of Japan, east of the Korean Peninsula. The capital is Tokyo. Bonin Islands
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011565 Psoriasis A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis. Palmoplantaris Pustulosis,Pustular Psoriasis of Palms and Soles,Pustulosis Palmaris et Plantaris,Pustulosis of Palms and Soles,Psoriases
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D005260 Female Females
D005787 Gene Frequency The proportion of one particular in the total of all ALLELES for one genetic locus in a breeding POPULATION. Allele Frequency,Genetic Equilibrium,Equilibrium, Genetic,Allele Frequencies,Frequencies, Allele,Frequencies, Gene,Frequency, Allele,Frequency, Gene,Gene Frequencies
D005838 Genotype The genetic constitution of the individual, comprising the ALLELES present at each GENETIC LOCUS. Genogroup,Genogroups,Genotypes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000071450 ATP Binding Cassette Transporter, Subfamily B, Member 3 ATP-binding cassette, subfamily B, protein that functions in the transport of ANTIGENS from the CYTOPLASM to the ENDOPLASMIC RETICULUM for association with HISTOCOMPATIBILITY ANTIGENS CLASS I peptides. It functions as a heterodimer with ATP BINDING CASSETTE TRANSPORTER, SUBFAMILY B, MEMBER 2. ABCB3 Protein,ATP Binding Cassette Transporter, Sub-Family B, Member 3,ATP-Binding Cassette, Sub-Family B, Member 3,Antigen Peptide Transporter-2,Peptide Supply Factor 2,Peptide Transporter Tap2,Antigen Peptide Transporter 2,Tap2, Peptide Transporter

Related Publications

H Saeki, and S Kuwata, and H Nakagawa, and A Asahina, and K Tamaki, and Y Shibata, and T Juji
October 1998, Tissue antigens,
H Saeki, and S Kuwata, and H Nakagawa, and A Asahina, and K Tamaki, and Y Shibata, and T Juji
March 2006, Saudi medical journal,
H Saeki, and S Kuwata, and H Nakagawa, and A Asahina, and K Tamaki, and Y Shibata, and T Juji
May 1997, Tissue antigens,
H Saeki, and S Kuwata, and H Nakagawa, and A Asahina, and K Tamaki, and Y Shibata, and T Juji
June 1998, The Journal of rheumatology,
H Saeki, and S Kuwata, and H Nakagawa, and A Asahina, and K Tamaki, and Y Shibata, and T Juji
April 1999, Tissue antigens,
H Saeki, and S Kuwata, and H Nakagawa, and A Asahina, and K Tamaki, and Y Shibata, and T Juji
September 2000, The Southeast Asian journal of tropical medicine and public health,
H Saeki, and S Kuwata, and H Nakagawa, and A Asahina, and K Tamaki, and Y Shibata, and T Juji
July 1999, Investigative ophthalmology & visual science,
H Saeki, and S Kuwata, and H Nakagawa, and A Asahina, and K Tamaki, and Y Shibata, and T Juji
September 1998, Tissue antigens,
H Saeki, and S Kuwata, and H Nakagawa, and A Asahina, and K Tamaki, and Y Shibata, and T Juji
January 2002, Journal of cutaneous medicine and surgery,
H Saeki, and S Kuwata, and H Nakagawa, and A Asahina, and K Tamaki, and Y Shibata, and T Juji
July 1998, Tissue antigens,
Copied contents to your clipboard!